Management of Gastrointestinal Disorders
Assessment and Diagnosis
- The British Society of Gastroenterology recommends assessing for Avoidant/Restrictive Food Intake Disorder (ARFID) in patients with severe or refractory functional dyspepsia presenting with weight loss and food restriction 1
- ARFID is a feeding disorder characterized by abnormal eating or feeding behaviors resulting in insufficient food intake to meet energy or nutritional requirements, leading to significant weight loss, nutritional deficiencies, or marked interference with psychosocial functioning, as defined by the American Academy of Pediatrics 2
- Assessment should include evaluation of nutritional status and growth parameters, assessment of specific food avoidance patterns, screening for comorbid anxiety disorders, ruling out other medical conditions, and distinguishing from other eating disorders 2
- The American Academy of Pediatrics recommends a multidimensional assessment for ARFID diagnosis, targeting the specific presentation pattern(s) of the disorder, with treatment approaches tailored to the underlying mechanism(s) 3
Treatment and Management
- The American Psychological Association suggests graded exposure therapy in a cognitive-behavioral framework for ARFID, rather than reinforcing restriction, with parenteral nutrition avoided except in life-threatening cases 3
- Treatment should be multidisciplinary and tailored to the specific presentation, with components including psychological interventions, food exposure therapy, psychoeducation, and nutritional rehabilitation 3
- The optimal psychological and nutritional rehabilitation approach in ARFID is graded exposure in a cognitive behavioral therapy setting, as recommended by clinical nutrition guidelines 3
- Avoid parenteral nutrition except in life-threatening malnutrition as a temporary bridge to appropriate therapies, highlighting the importance of careful nutritional management 3
- The Academy of Nutrition and Dietetics advises against reinforcing avoidance through unnecessary elimination diets, and inappropriate use of supplements can lead to dependence without addressing underlying factors 3
Comorbidities and Complications
- There is significant overlap with gastrointestinal disorders and functional dyspepsia, as well as comorbidity with disorders of gut-brain interaction (DGBI) and hypermobility disorders/hypermobile Ehlers-Danlos Syndrome 1, 3
- ARFID can lead to serious medical complications, including malnutrition, significant weight loss, growth stunting in children, nutritional deficiencies, dependence on nutritional supplements, and impaired psychosocial functioning 2
- Misdiagnosis can occur by failing to distinguish ARFID from anorexia nervosa or other eating disorders, and overlooking comorbidities such as anxiety disorders or gastrointestinal conditions 3
Pharmacological Interventions
- The ESPEN guideline suggests considering prokinetic agents for early satiety in cancer patients, but warns about potential adverse effects of domperidone on cardiac rhythm 4
- In patients with systemic sclerosis and gastrointestinal involvement, domperidone has shown some improvement in GERD symptoms, although 17% of patients did not respond to this therapy 5